Merrimack Historical Income Statement
| MACK Stock | USD 14.68 0.05 0.34% |
Historical analysis of Merrimack Pharmaceuticals income statement accounts such as Total Operating Expenses of 2.1 M can show how well Merrimack Pharmaceuticals performed in making a profits. Evaluating Merrimack Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Merrimack Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Merrimack Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Merrimack Pharmaceuticals is a good buy for the upcoming year.
Merrimack |
About Merrimack Income Statement Analysis
Merrimack Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Merrimack Pharmaceuticals shareholders. The income statement also shows Merrimack investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Merrimack Pharmaceuticals Income Statement Chart
Merrimack Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Merrimack's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Merrimack Pharmaceuticals revenue and expense. Merrimack Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Merrimack Pharmaceuticals' Total Revenue is quite stable compared to the past year. Total Other Income Expense Net is expected to rise to about 1.1 M this year, although the value of Gross Profit is projected to rise to (486.2 K). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Merrimack Pharmaceuticals. It is also known as Merrimack Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Merrimack Pharmaceuticals income statement and represents the costs associated with goods and services Merrimack Pharmaceuticals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Merrimack Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Merrimack Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merrimack Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.At this time, Merrimack Pharmaceuticals' Total Revenue is quite stable compared to the past year. Total Other Income Expense Net is expected to rise to about 1.1 M this year, although the value of Gross Profit is projected to rise to (486.2 K).
| 2023 | 2024 (projected) | Total Operating Expenses | 2.2M | 2.1M | Cost Of Revenue | 400.5K | 380.5K |
Merrimack Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Merrimack Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Merrimack Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (1.5M) | (2.3M) | (288K) | (890K) | (801K) | (761.0K) | |
| Interest Expense | 1.5M | 141K | 20K | (188K) | (169.2K) | (160.7K) | |
| Gross Profit | (67.3M) | (49.0M) | (2.2M) | (445K) | (511.8K) | (486.2K) | |
| Other Operating Expenses | 27.3M | 5.0M | 2.6M | 2.2M | 2.2M | 2.1M | |
| Operating Income | (22.4M) | (2.9M) | (2.5M) | (1.7M) | (2.2M) | (2.3M) | |
| Ebit | (22.4M) | (2.9M) | (2.5M) | (1.7M) | (2.0M) | (2.1M) | |
| Ebitda | (23.9M) | (5.2M) | (2.8M) | (2.6M) | (2.2M) | (2.3M) | |
| Cost Of Revenue | 67.3M | 49.0M | 2.2M | 445K | 400.5K | 380.5K | |
| Total Operating Expenses | 27.3M | 5.0M | 2.6M | 2.2M | 2.2M | 2.1M | |
| Income Before Tax | (22.7M) | (3.0M) | (2.5M) | (1.5M) | (1.2M) | (1.2M) | |
| Total Other Income Expense Net | (381K) | (141K) | 20K | 188K | 1.0M | 1.1M | |
| Net Income | (21.3M) | (3.0M) | (2.5M) | (1.5M) | (1.2M) | (1.2M) | |
| Income Tax Expense | (7.7M) | (1.5M) | 14K | 3K | 12K | 12.6K | |
| Selling General Administrative | 16.2M | 5.0M | 2.6M | 2.2M | 2.2M | 2.1M | |
| Net Income From Continuing Ops | (21.3M) | (3.0M) | (2.5M) | (1.5M) | (1.4M) | (1.5M) | |
| Non Operating Income Net Other | (1.9M) | 1.1M | (141K) | 188K | 169.2K | 160.7K | |
| Net Income Applicable To Common Shares | (17.3M) | (3.0M) | (2.5M) | (1.5M) | (1.8M) | (1.9M) | |
| Tax Provision | (7.7M) | (1.5M) | 14K | 3K | 12K | 12.6K | |
| Interest Income | 777K | 50K | 20K | 188K | 724K | 687.8K | |
| Net Interest Income | (751K) | 50K | 20K | 188K | 724K | 760.2K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merrimack Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Merrimack Stock analysis
When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Merrimack Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merrimack Pharmaceuticals. If investors know Merrimack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merrimack Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.08) | Return On Assets (0.07) | Return On Equity (0.06) |
The market value of Merrimack Pharmaceuticals is measured differently than its book value, which is the value of Merrimack that is recorded on the company's balance sheet. Investors also form their own opinion of Merrimack Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Merrimack Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merrimack Pharmaceuticals' market value can be influenced by many factors that don't directly affect Merrimack Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merrimack Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Merrimack Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merrimack Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.